Rational Design of Antigens to Improve the Serodiagnosis of Tick-Borne Borreliosis in Central Regions of Russia

  • Evgenia BaranovaEmail author
  • Pavel Solov′ev
  • Evgeny Panfertsev
  • Anastasia Baranova
  • Galina Feduykina
  • Liubov Kolombet
  • Muhammad G. Morshed
  • Sergey Biketov
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 807)


Tick-borne borreliosis (Lyme disease-LD) is caused by pathogenic Borrelia spirochetes that is transmitted through bite of Ixodes ticks to humans and animals. In the Russian Federation, borreliosis registered with an index of 6–7 per 100,000 people annually. In reality, LD morbidity in Russia is much higher because Russian strains develop less erythematous rashes compared to North American strains, thus missed by physicians in most of the early cases, and current serology tests have insufficient sensitivity as well. The aim of this work was to improve the sensitivity and specificity of serology tests for LD in Russia using rationale-designed Borrelia antigens. It was anticipated that sensitivity of LD sero-diagnosis will be higher if antigen for test-systems are derived from a strain that is circulated in a geographical region of test application. A large portion of the Russian population lives in the Central region. Thus, effort has been made to create a serological test using antigens from Moscow region, Tula and Ul’janovsk areas. In this study we included wild strains (ultrasonic-treated spirochetes B. garinii H19, B. afzelii P1, B. afzelii P1H13, B. burgdorferi s.s. 39/40, B. burgdorferi s.s. B31), recombinant (expressed in E.coli DbpA, Bgp, Bbk B. garinii, and B. afzelii) antigens and some of their combinations were produced and tested against LD patients and donors serum collected in hospitals of Central regions of Russia by ELISA and Western blotting. Considering sensitivity and specificity, DbpA B. afzelii and DbpA B. garinii recombinant antigens were selected among all probed antigens for regional serology test. As long as DbpA B. afzelii and DbpA B. garinii antigens interacted with LD patient’s serum in a complementary mode, it is possible to combine epitopes DbpA B. afzelii and B. garinii in a single antigen for improving sensitivity. We created recombinant fusion protein DbpA B. afzelii/B using dbpA genes from Russian isolates of B. afzelii and B. garinii in E. coli. Fusion DbpA A + G protein was then used for formulation of fast immunochromatographic serodiagnosis test (LF) in a “deep-stick” format. The trials of LF-test were conducted separately at Institute of Rheumatology Russian Academy of Medical Science (using 325 sera) and at the Borreliosis Reference Center of Ministry of Health RF (using 120 reference sera). The average sensitivity and specificity of LF-test was 80.5 and 100 %, respectively.


Lyme disease Borrelia garinii Borrelia afzelii DbpA Serology LF-test 



This work was performed within framework of the International Science and Technology Center Project #2738.


  1. 1.
    Tugwell P, Dennis DT, Weinstein A, Wells G, Shea B, Nichol G, Hayward R, Lighfoot R, Barker P, Steere AC (1997) Clinical guideline part 2: laboratory evaluation in diagnosis of Lyme disease. Ann Intern Med 127:1109–1123CrossRefGoogle Scholar
  2. 2.
    Steere AS, Coburn J, Gilckstain L (2004) The emergence of Lyme disease. J Clin Investig 113(8):1093–1101CrossRefGoogle Scholar
  3. 3.
    Liang FT, Steere AS, Marques AR, Johnson BJB, Miller JN, Philipp MT (1999) Sensitive and specific serodiagnosis of Lyme disease by Enzyme-Linked Immunosorbent Assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi Vls. Eur J Clin Microbiol 37:3990–3996Google Scholar
  4. 4.
    Wang G, Alje P, van Dam AP, Schwarz I, Dankert J (1999) Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin Microb Rev 12(4):633–653Google Scholar
  5. 5.
    Baranton G, Postic D, Saint Girons I, Boerlin P, Piffaretti JC, Assous M, Grimont PA (1992) Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int J Syst Bacteriol 42:378–383Google Scholar
  6. 6.
    Morshed MG, Scott JD, Fernando K, Geddes G, McNabb A, Mak S, Durden LA (2006) Distribution and characterization of Borrelia burgdorferi isolates from Ixodes scapularis and presence in mammalian hosts in Ontario, Canada. J Med Entomol 43(4):762CrossRefGoogle Scholar
  7. 7.
    Burgdorfer W, Anderson JF, Gern L, Lane RS, Piesman J, Spielman A (1991) Relationship of Borrelia burgdorferi to its arthropod vectors. Scand J Infect Dis Suppl 77:35–40Google Scholar
  8. 8.
    Wang G, van Dam AP, Le Fleche A, Postic D, Peter O, Baranton G, de Boer R, Spanjaard L (1997) Dankert J Genetic and phenotypic analysis of Borrelia valaisiana sp. Nov. (Borrelia genomic groups VS116 and M 19). Int J Syst Bacteriol 47:926–932CrossRefGoogle Scholar
  9. 9.
    Mun J, Eisen RJ, Eisen L, Lane RS (2006) Detection of a Borrelia miyamotoi sensu lato relapsing-fever group spirochete from Ixodes pacificus in California. J Med Entomol 43:120–3. PubMed doi: 10.1603/0022-2585(2006)043[0120:DOABMS]2.0.CO;2Google Scholar
  10. 10.
    Huppertz HI, Bartmann P, Heininger U, Fingerle V, Kinet M, Klein R, Korenke GC, Nentwich HJ (2012) Rational diagnostic strategies for Lyme borreliosis in children and adolescents: recommendations by the Committee for Infectious Diseases and Vaccinations of the German Academy for Pediatrics and Adolescent Health. Eur J Pediatr 171(11):1619–1624Google Scholar
  11. 11.
    Nikolaenko VV, Korenberg EI, Vorobjeva NN, Roggenbruck D (2001) Using micromodification indirect IFA for serodiagnosis testing ixodi-born borreliosis. Med Parasitol 4:20–26Google Scholar
  12. 12.
    Shtannikov AV, Baranova EV, Evsegneev SI, Reshetnjak TV, Repolovskaya TV, Prilipov AG, Kolosova NV, Naumov RL, Biketov SF, Ananjeva LP (2001) Isolation and investigation of properties Borrelia burgdorferi sensu lato strains from clinical samples and ticks. In: Materials of seminar clinical perspective in infectology, “Ticks and parasitosis infections”, 1:35–38Google Scholar
  13. 13.
    Laemmly UK (1970) Cleavage of structural proteins during the assembly of the head of Bacteriophage T4. Nature 227:680–685CrossRefGoogle Scholar
  14. 14.
    Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Nat Acad Sci USA 76:4350–4354CrossRefGoogle Scholar
  15. 15.
    Ulbrandt ND, Cassatt DR, Patel NK, Roberts WC, Bachy CM, Fazenbaker CA, Hanson MS (2001) Conformational nature of the Borrelia burgdorferi decorin binding protein A epitopes that elicit protective antibodies. Infect Immun 69(8):4799–4807CrossRefGoogle Scholar
  16. 16.
    Cassatt DR, Patel NK, Ulbrandt ND, Hanson MS (1998) DbpA, but not OspA, is expressed by Borrelia burgdorferi during spirochetemia and is a target for protective antibodies. Infect Immun 66(11):5379–5387Google Scholar
  17. 17.
    Schulte-Spechtel U, Fingerle V, Goettner G, Rogge S, Wilske B (2006) Molecular analysis of decorin-binding protein A (DbpA) reveals five major groups among European Borrelia burgdorferi sensu lato strains with impact for the development of serological assays and indicates lateral gene transfer of the dbpA gene. Int J Med Microbiol 296(40):250–266CrossRefGoogle Scholar
  18. 18.
    Panfertsev E, Mochalov VV, Baranova EV, Kolosova NV, Solov’ev PV, Shtannikov AV, Prilipov AG, Morshed MG, Biketov SF (2009) Design of a novel technology for Borrelia DbpA protein construction using recombinant E. coli strains-producers for serological diagnostics of tick-born borreliosis. In: Materials of 12th SAC seminar combating global infections, Irkutsk, p 54Google Scholar

Copyright information

© Springer India 2014

Authors and Affiliations

  • Evgenia Baranova
    • 1
    Email author
  • Pavel Solov′ev
    • 1
  • Evgeny Panfertsev
    • 1
  • Anastasia Baranova
    • 1
  • Galina Feduykina
    • 1
  • Liubov Kolombet
    • 1
  • Muhammad G. Morshed
    • 2
    • 3
  • Sergey Biketov
    • 1
  1. 1.State Research Center for Applied Microbiology and BiotechnologyObolensk, Moscow regionRussia
  2. 2.British Columbia Centre for Disease Control Public Health Microbiology and Reference LaboratoryVancouverCanada
  3. 3.Department of Pathology and Laboratory MedicineUniversity of British ColumbiaVancouverCanada

Personalised recommendations